VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
VolitionRx signed a non-binding agreement with Missionpharma to potentially develop and launch a lateral flow technology for NETosis.· summarised by Stockedin
VNRX